Comparison

GLP-1 receptor agonist 4 European Partner

Item no. HY-129657-100mg
Manufacturer MedChem Express
CASRN 1187061-62-6
Amount 100 mg
Quantity options 100 mg 1 ea
Category
Type Chemicals
Specific against other
Citations [1]Adnan M.M. Mjalli,et al. Oxadiazoanthracene compounds for the treatment of diabetes. WO2009111700A2.
Smiles O=C(O)[C@@H](NC([C@@H]1CC2=C(CN1[C@H](C3=CC=CC=C3)CC)C=C(O[C@H](C4=CC=C(OCC5=CC=C(Cl)C(Cl)=C5)C=C4)C(N6C)=O)C6=C2)=O)CC7=CC=C(C8=CC=C(C#N)C=C8)C=C7
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
GLP-1 receptor agonist 4 is a glucagon-like peptide-1 receptor (GLP-1R) agonist extracted from patent WO2009111700A2, compound 87, has an EC50 of 64.5 nM. GLP-1 receptor agonist 4 can be used in the research for treatment of diabetes[1].
Shipping
Room temperature
Manufacturers Applications
Metabolism-sugar/lipid metabolism
MolecularWeight
879.82
Clinical Information
No Development Reported
Manufacturers Research Area
Metabolic Disease
Solubility
10 mM in DMSO
Target
GCGR
Manufacturers Target
GCGR
Manufacturers Pathway
GPCR/G Protein
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close